Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis.
Saved in:
| Title: | Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis. |
|---|---|
| Authors: | Guyon J; University Bordeaux, INSERM U1312, BRIC, Pessac, France., Fernandez-Moncada I; University Bordeaux, INSERM, U1215 Neurocentre Magendie, Bordeaux, France., Larrieu CM; University Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, France., Bouchez CL; University Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, France., Pagano Zottola AC; University Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, France., Galvis J; University Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, France.; Bordeaux Bioinformatic Center CBiB, University of Bordeaux, Bordeaux, France., Chouleur T; University Bordeaux, INSERM U1312, BRIC, Pessac, France., Burban A; University Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, France., Joseph K; Microenvironment and Immunology Research Laboratory, Medical Center, University of Freiburg, Freiburg, Germany.; Department of Neurosurgery, Medical Center, University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Translational NeuroOncology Research Group, Medical Center, University of Freiburg, Freiburg, Germany.; Center of Advanced Surgical Tissue Analysis (CAST), University of Freiburg, Freiburg, Germany., Ravi VM; Microenvironment and Immunology Research Laboratory, Medical Center, University of Freiburg, Freiburg, Germany.; Department of Neurosurgery, Medical Center, University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Translational NeuroOncology Research Group, Medical Center, University of Freiburg, Freiburg, Germany.; Center of Advanced Surgical Tissue Analysis (CAST), University of Freiburg, Freiburg, Germany.; Freiburg Institute for Advanced Studies (FRIAS), University of Freiburg, Freiburg, Germany., Espedal H; NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway., Røsland GV; University Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, France., Daher B; University Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, France., Barre A; Bordeaux Bioinformatic Center CBiB, University of Bordeaux, Bordeaux, France., Dartigues B; Bordeaux Bioinformatic Center CBiB, University of Bordeaux, Bordeaux, France., Karkar S; Bordeaux Bioinformatic Center CBiB, University of Bordeaux, Bordeaux, France., Rudewicz J; Bordeaux Bioinformatic Center CBiB, University of Bordeaux, Bordeaux, France., Romero-Garmendia I; University Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, France., Klink B; Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg.; German Cancer Consortium (DKTK), Dresden, Germany.; Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases (NCT), Dresden, Germany., Grützmann K; Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases (NCT), Dresden, Germany., Derieppe MA; Animal Facility, University Bordeaux, Pessac, France., Molinié T; University Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, France., Obad N; NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway., Léon C; University Bordeaux, INSERM U1312, BRIC, Pessac, France., Seano G; Institut Curie, INSERM U1021, CNRS UMR3347, Tumor Microenvironment Lab, University Paris-Saclay, Orsay, France., Miletic H; NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway.; Department of Pathology, Haukeland University Hospital, Bergen, Norway., Heiland DH; Microenvironment and Immunology Research Laboratory, Medical Center, University of Freiburg, Freiburg, Germany.; Department of Neurosurgery, Medical Center, University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Translational NeuroOncology Research Group, Medical Center, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), partner site Freiburg, Freiburg, Germany., Marsicano G; University Bordeaux, INSERM, U1215 Neurocentre Magendie, Bordeaux, France., Nikolski M; University Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, France.; Bordeaux Bioinformatic Center CBiB, University of Bordeaux, Bordeaux, France., Bjerkvig R; NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway., Bikfalvi A; University Bordeaux, INSERM U1312, BRIC, Pessac, France., Daubon T; University Bordeaux, INSERM U1312, BRIC, Pessac, France.; University Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, France. |
| Source: | EMBO molecular medicine [EMBO Mol Med] 2022 Dec 07; Vol. 14 (12), pp. e15343. Date of Electronic Publication: 2022 Oct 24. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1757-4684 |
|---|---|
| DOI: | 10.15252/emmm.202115343 |
